These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 7372666)

  • 1. Effects of pyridoxal 5'-phosphate on uterine estrogen receptor. I. Inhibition of nuclear binding in cell-free system and intact uterus.
    Müller RE; Traish A; Wotiz HH
    J Biol Chem; 1980 May; 255(9):4062-7. PubMed ID: 7372666
    [No Abstract]   [Full Text] [Related]  

  • 2. Specific modification of rat uterine estrogen receptor by pyridoxal 5'-phosphate.
    Muldoon TG; Cidlowski JA
    J Biol Chem; 1980 Apr; 255(7):3100-7. PubMed ID: 7358732
    [No Abstract]   [Full Text] [Related]  

  • 3. Effect of pyridoxal 5'-phosphate on oligodeoxynucleotide binding of mouse uterine cytosol estradiol-receptor complexes.
    Henrikson KP; Gross SC; Dickerman HW
    Endocrinology; 1981 Oct; 109(4):1196-202. PubMed ID: 7285868
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of pyridoxal 5'-phosphate on uterine estrogen receptor. II. Inhibition of estrogen . receptor transformation.
    Traish A; Müller RE; Wotiz HH
    J Biol Chem; 1980 May; 255(9):4068-72. PubMed ID: 7372667
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Conditions for the measurement of nuclear estrogen receptor at low temperature.
    Okulicz WC; Boomsma RA; MacDonald RG; Leavitt WW
    Biochim Biophys Acta; 1983 May; 757(1):128-36. PubMed ID: 6838903
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Uterine receptor-estradiol complexes and their interaction with nuclear binding sites.
    Clark JH; Eriksson HA; Hardin JW
    J Steroid Biochem; 1976; 7(11-12):1039-43. PubMed ID: 1025347
    [No Abstract]   [Full Text] [Related]  

  • 7. Quantitation of nuclear-estrogen receptors in the rat uterus by [3H]-estradiol exchange.
    Markaverich BM; Clark JH
    J Steroid Biochem; 1981 Dec; 15():289-92. PubMed ID: 7339255
    [No Abstract]   [Full Text] [Related]  

  • 8. Estrogen-binding properties of cytoplasmic and nuclear estrogen receptors in the presence of Triton X-100.
    Pavlik EJ; Rutledge S
    J Steroid Biochem; 1980 Dec; 13(12):1433-41. PubMed ID: 7464123
    [No Abstract]   [Full Text] [Related]  

  • 9. Conversion of estrogen receptor from a state with low affinity for estradiol into a state of higher affinity does not require 4S to 5S dimerization.
    Müller RE; Traish AM; Hirota T; Bercel E; Wotiz HH
    Endocrinology; 1985 Jan; 116(1):337-45. PubMed ID: 2981069
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Binding of monoclonal antibodies to the nuclear estrogen receptor in intact nuclei.
    Moncharmont B; Parikh I
    Biochem Biophys Res Commun; 1983 Jul; 114(1):107-12. PubMed ID: 6882416
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nuclear interaction of Fusarium mycotoxins with estradiol binding sites in the mouse uterus.
    Greenman DL; Mehta RG; Wittliff JL
    J Toxicol Environ Health; 1979 Jul; 5(4):593-8. PubMed ID: 490675
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Two binding sites for estradiol in rat uterine nuclei: relationship to uterotropic response.
    Markaverich BM; Clark JH
    Endocrinology; 1979 Dec; 105(6):1458-62. PubMed ID: 574077
    [No Abstract]   [Full Text] [Related]  

  • 13. Estradiol: alterations in the mechanism of intracellular transport.
    Lobl RT
    Psychoneuroendocrinology; 1975; 1(2):131-40. PubMed ID: 1234652
    [No Abstract]   [Full Text] [Related]  

  • 14. Estrogen binding in the rat uterus: heterogeneity of sites and relation to uterotrophic response.
    Eriksson HA; Hardin JW; Markaverich B; Upchurch S; Clark JH
    J Steroid Biochem; 1980 Jan; 12():121-30. PubMed ID: 7421201
    [No Abstract]   [Full Text] [Related]  

  • 15. Extensive in situ activation of nuclear estrogen receptors after exposure of murine uteri to [3H]estradiol or [3H]4-hydroxytamoxifen.
    Pavlik EJ; Nelson K; van Nagell JR; Donaldson ES; Walden ML; Gallion H; Kenady DE
    Endocrinology; 1987 Apr; 120(4):1608-14. PubMed ID: 3830064
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of intercalating drugs on the release of uterine nuclear estrogen receptors.
    Schoenberg DR; Clark JH
    J Biol Chem; 1979 Sep; 254(17):8270-5. PubMed ID: 468824
    [No Abstract]   [Full Text] [Related]  

  • 17. Reversible inhibition of estrogen receptor activation by molybdate.
    Müller RE; Traish AM; Beebe DA; Wotiz HH
    J Biol Chem; 1982 Feb; 257(3):1295-300. PubMed ID: 7056718
    [No Abstract]   [Full Text] [Related]  

  • 18. Progesterone action in hamster uterus: rapid inhibition of 3H-estradiol retention by the nuclear fraction.
    Evans RW; Leavitt WW
    Endocrinology; 1980 Oct; 107(4):1261-3. PubMed ID: 7408773
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Heterogeneity of nuclear estrogen-binding sites in the rat uterus: a simple method for the quantitation of type I and type II sites by [3H]estradiol exchange.
    Markaverich BM; Williams M; Upchurch S; Clark JH
    Endocrinology; 1981 Jul; 109(1):62-9. PubMed ID: 7238414
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Heterogeneity of estrogen receptors in the cytosol and nuclear fractions of the rat uterus.
    Eriksson H; Upchurch S; Hardin JW; Peck EJ; Clark JH
    Biochem Biophys Res Commun; 1978 Mar; 81(1):1-7. PubMed ID: 656088
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.